Nikkhil K Masurkar, the CEO of Entod, stated that PresVu has been specifically created to remove the necessity for reading glasses in people aged 40 to 55 who experience mild to moderate presbyopia, offering a practical solution compared to conventional options such as reading glasses.
PresVu eye drops, created at the research and development center of Entod Pharmaceuticals in India, achieved final approval from the Drug Controller General of India (DCGI) on Tuesday, September 3. This milestone represents a major breakthrough in the management of presbyopia, according to reports. Nikkhil K Masurkar, the CEO of the Mumbai-based company, hailed PresVu as a “groundbreaking solution for presbyopia.”
Masurkar announced on LinkedIn four months ago that PresVu is a groundbreaking eye drop in India, specifically created to help individuals aged 40 to 55 with mild to moderate presbyopia. This innovative solution offers a practical alternative to conventional reading glasses, revolutionizing how we address this common vision issue.
In a LinkedIn update from May, Masurkar highlighted that PresVu had received prior approval from the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO). He noted, “This approval follows the successful completion of multi-centric phase 3 clinical trials conducted in India by ENTOD.”
What’s the significance of the name PresVu, and what exactly is Presbyopia?
Entod Pharmaceuticals has pioneered the development of PresVu, a groundbreaking solution aimed at minimizing the reliance on reading glasses for those suffering from Presbyopia. This innovative product marks the first introduction of such eye drops in India, setting a new standard in eye care.
Presbyopia refers to the slow decline in the eye’s capacity to focus on close-up items, as described by the Mayo Clinic. This condition is a normal aspect of aging, typically becoming apparent in individuals during their early to mid-40s and progressively intensifying until around the age of 65.
CEO Masurkar emphasized that this therapy has undergone extensive testing for both effectiveness and safety in Indian patients and has also received approval from the US FDA.
What is the expected release date for PresVu eye drops in India?
As reported by the news agency PTI, the Mumbai-based pharmaceutical company is set to launch PresVu eye drops in the domestic market during the first week of October.
Masurkar emphasized that the company is committed to addressing the needs of both domestic and emerging markets, particularly in Africa and Southeast Asia. He highlighted the company’s strategy to develop innovative products in India, with plans to subsequently license them for the US market.
What is the price of PresVu eye drops in India?
On Tuesday, the company announced that a single vial of PresVu eye drops will be priced at ₹345, as reported by The New India Express and The Print. This vial is intended to provide a month’s supply for users.
How to use PresVu?
It is generally required for individuals to administer the medication once a day, with effects that can persist for several hours, as noted by Print. The eye drops should only be used with a prescription from an ophthalmologist. Each eye should receive just one drop daily, providing an effect that lasts approximately six hours. If needed, an additional drop can be applied to each eye three to six hours after the initial application, potentially enhancing clarity for an extra three hours. According to Entod Pharmaceuticals, the medication begins to take effect within 15 minutes of application, although the full benefits are expected to be realized after 15 days of consistent use.